Invesco Ltd. Has $7.31 Million Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Invesco Ltd. lessened its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 12.9% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 373,839 shares of the company's stock after selling 55,556 shares during the period. Invesco Ltd. owned 0.31% of Privia Health Group worth $7,309,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in PRVA. Rhumbline Advisers increased its stake in shares of Privia Health Group by 1.3% in the 4th quarter. Rhumbline Advisers now owns 287,200 shares of the company's stock valued at $5,615,000 after buying an additional 3,658 shares during the period. Nordea Investment Management AB lifted its stake in Privia Health Group by 33.1% in the fourth quarter. Nordea Investment Management AB now owns 349,773 shares of the company's stock valued at $6,953,000 after buying an additional 86,910 shares in the last quarter. Franklin Resources Inc. boosted its position in shares of Privia Health Group by 2.2% during the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company's stock worth $23,092,000 after buying an additional 28,480 shares during the period. Barclays PLC raised its holdings in shares of Privia Health Group by 240.3% in the third quarter. Barclays PLC now owns 224,018 shares of the company's stock valued at $4,079,000 after purchasing an additional 158,188 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its position in Privia Health Group by 8.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company's stock worth $3,430,000 after buying an additional 14,641 shares in the last quarter. 94.48% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have issued reports on PRVA shares. Robert W. Baird upped their price target on shares of Privia Health Group from $24.00 to $26.00 and gave the stock an "outperform" rating in a research report on Tuesday, April 15th. Barclays upped their price objective on Privia Health Group from $21.00 to $23.00 and gave the company an "equal weight" rating in a research note on Thursday, April 10th. Piper Sandler boosted their target price on Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a report on Friday, February 28th. Truist Financial lifted their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the stock a "buy" rating in a research report on Thursday, April 10th. Finally, Stephens reiterated an "overweight" rating and issued a $26.00 price target on shares of Privia Health Group in a research note on Thursday, January 2nd. One investment analyst has rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Buy" and an average price target of $27.14.

Privia Health Group Stock Up 0.3 %

Shares of NASDAQ:PRVA traded up $0.07 during trading on Wednesday, reaching $23.48. 715,313 shares of the company traded hands, compared to its average volume of 772,769. The firm has a market capitalization of $2.85 billion, a PE ratio of 234.82, a PEG ratio of 3.47 and a beta of 0.88. Privia Health Group, Inc. has a 52 week low of $15.92 and a 52 week high of $26.04. The company's 50 day moving average is $23.55 and its two-hundred day moving average is $22.00.

Insider Activity at Privia Health Group

In other news, CFO David Mountcastle sold 5,630 shares of the business's stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total value of $125,999.40. Following the completion of the transaction, the chief financial officer now directly owns 179,676 shares in the company, valued at approximately $4,021,148.88. The trade was a 3.04 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 10.70% of the stock is owned by insiders.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.